Martin J Hug

Summary

Affiliation: University Hospital
Country: Germany

Publications

  1. ncbi Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial)
    Jürgen Eckes
    Medical Practice, Altdorfstr 10, Emmendingen, Germany
    BMC Cancer 11:337. 2011
  2. ncbi Measurement of ion transport function in rectal biopsies
    Martin J Hug
    Pharmacy, University Medical Center Freiburg, D 79106, Freiburg, Germany
    Methods Mol Biol 741:87-107. 2011
  3. ncbi How to measure CFTR-dependent bicarbonate transport: from single channels to the intact epithelium
    Martin J Hug
    Pharmacy, University Medical Center Freiburg, Freiburg, Germany
    Methods Mol Biol 741:489-509. 2011
  4. ncbi Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy
    Gerhard Putz
    University Freiburg Medical Center, Department Clinical Chemistry, Hugstetter Street 55, D 79106 Freiburg, Germany
    Med Hypotheses 72:393-7. 2009
  5. ncbi Controlled application and removal of liposomal therapeutics: effective elimination of pegylated liposomal doxorubicin by double-filtration plasmapheresis in vitro
    Gerhard Putz
    Department of Clinical Chemistry, University Medical Center Freiburg, Freiburg, Germany
    J Clin Apher 25:54-62. 2010

Collaborators

  • Gerhard Putz
  • Nico Derichs
  • Jürgen Eckes
  • Annette Hasenburg
  • Martin Jansen
  • Jan W Siebers
  • Karl Winkler
  • Ursula Groh
  • Stefan Zschiedrich
  • Oliver Schmah
  • Beate Rautenberg

Detail Information

Publications5

  1. ncbi Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial)
    Jürgen Eckes
    Medical Practice, Altdorfstr 10, Emmendingen, Germany
    BMC Cancer 11:337. 2011
    ..Once saturation in tumor tissue is achieved, most of the administered DDS still circulate in the plasma. The extracorporeal elimination of these circulating nanoparticles would probably reduce toxicity...
  2. ncbi Measurement of ion transport function in rectal biopsies
    Martin J Hug
    Pharmacy, University Medical Center Freiburg, D 79106, Freiburg, Germany
    Methods Mol Biol 741:87-107. 2011
    ..In this chapter we will review the different approaches to perform ion transport measurements and try to highlight the advantages and limitations of these techniques...
  3. ncbi How to measure CFTR-dependent bicarbonate transport: from single channels to the intact epithelium
    Martin J Hug
    Pharmacy, University Medical Center Freiburg, Freiburg, Germany
    Methods Mol Biol 741:489-509. 2011
    ..In this chapter we will review some of the techniques available to measure bicarbonate transport through single ion channels, individual cells, and intact epithelial layers...
  4. ncbi Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy
    Gerhard Putz
    University Freiburg Medical Center, Department Clinical Chemistry, Hugstetter Street 55, D 79106 Freiburg, Germany
    Med Hypotheses 72:393-7. 2009
    ..In conclusion, the combination of DDS and scheduled apheresis may allow the development of new chemotherapy regiments with higher impact and/or less toxicity...
  5. ncbi Controlled application and removal of liposomal therapeutics: effective elimination of pegylated liposomal doxorubicin by double-filtration plasmapheresis in vitro
    Gerhard Putz
    Department of Clinical Chemistry, University Medical Center Freiburg, Freiburg, Germany
    J Clin Apher 25:54-62. 2010
    ..Finding a way to detoxify the predominant part of a given dose, circulating in the blood after accumulation is completed, will presumably reduce severe side effects during chemotherapy...